Published 2 months ago

RxHCC Model May Not Accurately Predict Costs for Certain TAs

Summary by Avalere Health

Background The Inflation Reduction Act (IRA) significantly redesigns the Part D benefit in 2025 and changes liability between stakeholders, including beneficiaries, manufacturers, and plans. Under Part D redesign, plans will assume additional liability in the catastrophic phase where plan liability will increase from 15% in 2023 to 60%. Additionally, Part D redesign eliminates the coverage gap leaving plans liable for 65% of drug spending that …

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated2 months agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

RxHCC Model May Not Accurately Predict Costs for Certain TAs

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics